Új vizsgálatok, publikációk, preprintek és pályázatok ezen a célponton, hónapról hónapra.
Publikáció
Circulating Tumor DNA Profiling Across Phase II/III Ewing Sarcoma Trials Identifies High-Risk Patients With TP53, STAG2, and CDKN2A Alterations.
2026. nov. 4.· Journal of clinical oncology : official journal of the American Society of Clinical Oncology· PUBMED
Publikáció
Expression of CDKN2A Gene for Early Detection of Head and Neck Squamous Cell Carcinoma - An Evaluative Study.
2026. okt. 28.· Indian journal of dental research : official publication of Indian Society for Dental Research· PUBMED
Publikáció
EGFRvIII overexpression and loss of mouse-specific CDKN2A in glial cells leads to spontaneous gliomagenesis in a novel mouse model.
2026. okt. 24.· Neuro-oncology· PUBMED
Publikáció
Association of CDKN2A overexpression with poor prognosis, radioresistance, and immunosuppression in colorectal cancer.
2026. okt. 16.· Frontiers in cell and developmental biology· PUBMED
Publikáció
CDKN2A deletion associated with poor prognosis in patients with TERT promoter wild-type, IDH wild-type glioblastoma.
2026. okt. 10.· Brain tumor pathology· PUBMED
Publikáció
Pediatric and Adult Sinonasal Phosphaturic Mesenchymal Tumors: CDKN2A Copy Number Alterations and Their Association with Recurrence.
2026. okt. 6.· Head and neck pathology· PUBMED
Publikáció
CDKN2A alterations in solid tumors: From biological mechanisms to clinical applications, with special emphasis on central nervous system tumors.
2026. szept. 22.· Histology and histopathology· PUBMED
Publikáció
Assessing melanoma and pancreatic cancer risks in diverse CDKN2A heterozygote populations.
2026. szept. 22.· Genetics in medicine : official journal of the American College of Medical Genetics· PUBMED
Publikáció
Low frequency of MTAP co-deletion with CDKN2A in peritoneal mesothelioma suggests an independent diagnostic role for MTAP.
2026. szept. 21.· Histopathology· PUBMED
Publikáció
Exploring the Melanoma and Pancreatic Cancer Phenotype of a Potential CDKN2A Founder Variant, I49T (c.146T>C; p.Ile49Thr), in Individuals of Predominantly Mexican Ancestry.
2026. szept. 17.· JCO precision oncology· PUBMED
Publikáció
CDKN2A c.146T>C (I49T) in Mexican-ancestry individuals: Findings from melanoma and population cohorts.
2026. szept. 15.· JAAD international· PUBMED
Publikáció
Age-specific pancreatic cancer risk in Italian CDKN2A families.
2026. szept. 14.· Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver· PUBMED
Publikáció
A Pathway to Chordoma Treatment: A Review on CDKN2A and Therapeutic Targeting.
2026. aug. 19.· Cancers· PUBMED
Vizsgálat
A Comparative Usability Study of Two Total Body Skin Imaging Systems
2026. aug. 3.· NA · NOT_YET_RECRUITING· CTGOV
Vizsgálat
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
2026. júl. 27.· PHASE2 · RECRUITING· CTGOV
Publikáció
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.
2026. júl. 27.· Clinical cancer research : an official journal of the American Association for Cancer Research· PUBMED
Publikáció
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
2026. júl. 15.· JCO precision oncology· PUBMED
Publikáció
Immunohistochemical Loss of MTAP as a Diagnostic and Prognostic Surrogate of CDKN2A/B Homozygous Deletion: A Narrative Review.
2026. júl. 1.· Diagnostics (Basel, Switzerland)· PUBMED
Publikáció
The Role of STAG2, CDKN2A, and TP53 Genes in Ewing Sarcoma: A Report of a Rare Case of Primary Ewing Sarcoma of the Kidney With Favorable Outcome.
2026. jún. 29.· Journal of pediatric hematology/oncology· PUBMED
Publikáció
A Greek Case-Control Replication Study of IKZF1 rs4132601 and CDKN2A rs3731217 in Childhood Acute Lymphoblastic Leukemia.
2026. jún. 10.· Genes· PUBMED
Publikáció
Lower artificial intelligence and clinician-derived dermoscopy scores in melanomas from CDKN2A pathogenic variant carriers compared to sporadic cases.
2026. jún. 6.· Journal of the American Academy of Dermatology· PUBMED
Preprint
Disruption of CTCF binding by germline non-coding variants in CDKN2B suppress CDKN2A expression and predispose to melanoma.
2026. jún. 2.· medRxiv : the preprint server for health sciences· PUBMED
Publikáció
Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas.
2026. jún. 1.· Journal of neuropathology and experimental neurology· PUBMED
Publikáció
TP53, HIF1A, and CDKN2A in Hepatocellular Carcinoma: Roles in Senescence, Ferroptosis, and Prognosis.
2026. jún. 1.· Clinical and translational gastroenterology· PUBMED
Publikáció
CDKN2A alterations as possible molecular link between environmental pollutants and pathogenesis of liver cancer: Epidemiology, mechanisms, and insights.
2026. máj. 27.· Hepatobiliary & pancreatic diseases international : HBPD INT· PUBMED
Publikáció
Clinicogenomic Landscape of MTAP-Deleted Thoracic Malignancies Across US and Japanese Nationwide Cohorts: Impact of Concurrent CDKN2A Alterations and Driver Mutations.
2026. máj. 22.· JCO precision oncology· PUBMED
Preprint
Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma.
2026. máj. 18.· medRxiv : the preprint server for health sciences· PUBMED
Publikáció
Association between breast cancer, pancreatic cancer, and melanoma in a CDKN2A variant common in the Hispanic population.
2026. máj. 13.· Familial cancer· PUBMED
Publikáció
MTAP loss in gastrointestinal cancers is associated with CDKN2A deletion, poor prognosis in gastric carcinoma, and potential relevance for PRMT5-targeted therapy.
2026. máj. 13.· Scientific reports· PUBMED
Publikáció
Possible Founder Effect of the CDKN2A c.146T>C Variant in the Mexican Population: Phenotypic Characterization.
2026. ápr. 30.· Genes· PUBMED